These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20196977)

  • 21. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes and length of treatment with carbamazepine extended-release capsules in bipolar disorder.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():15-8. PubMed ID: 16754407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of carbamazepine extended-release capsules in patients with bipolar disorder: QD vs BID.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():27-30. PubMed ID: 16754410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
    Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W;
    Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
    Eden Evins A; Demopulos C; Nierenberg A; Culhane MA; Eisner L; Sachs G
    Bipolar Disord; 2006 Feb; 8(1):75-80. PubMed ID: 16411983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder.
    Joshi G; Wozniak J; Mick E; Doyle R; Hammerness P; Georgiopoulos A; Kotarski M; Aleardi M; Williams C; Walls S; Biederman J
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):7-14. PubMed ID: 20166791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of response to carbamazepine extended-release capsules treatment in bipolar disorder.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():23-6. PubMed ID: 16754409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
    Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Ketter TA; Keck PE; Swann A; Kalali A;
    CNS Drugs; 2006; 20(3):219-31. PubMed ID: 16529527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines for treatment-resistant mania in children with bipolar disorder.
    Scheffer RE; Tripathi A; Kirkpatrick FG; Schultz T
    J Psychiatr Pract; 2011 May; 17(3):186-93. PubMed ID: 21586996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switching from other agents to extended-release carbamazepine in acute mania.
    El-Mallakh RS; Ketter TA; Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Keck P; Swann AC; Kalali AH
    Psychopharmacol Bull; 2008; 41(1):52-8. PubMed ID: 18362871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended-release carbamazepine capsules : in bipolar I disorder.
    Swainston Harrison T; Keating GM
    CNS Drugs; 2005; 19(8):709-16. PubMed ID: 16097852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness, safety and practicality of delayed-release minitablets of valproate in bipolar affective disorders].
    Grunze H; Amann B; Schäfer M; Sterr A; Schaerer L; Wild E; Walden J
    Fortschr Neurol Psychiatr; 2000 Nov; 68(11):496-502. PubMed ID: 11144934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Reliability and concordance validity of a German version of the Young Mania Rating Scale (YMRS-D)].
    Mühlbacher M; Egger C; Kaplan P; Simhandl C; Grunze H; Geretsegger C; Whitworth A; Stuppäck C
    Neuropsychiatr; 2011; 25(1):16-25. PubMed ID: 21486540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended-release carbamazepine for acute bipolar mania: a review.
    Owen RT
    Drugs Today (Barc); 2006 May; 42(5):283-9. PubMed ID: 16801991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended-release carbamazepine capsules: a viewpoint.
    Weisler RH
    CNS Drugs; 2005; 19(8):717-8. PubMed ID: 16097854
    [No Abstract]   [Full Text] [Related]  

  • 37. Extended-release carbamazepine capsules: a viewpoint.
    Mitchell PB
    CNS Drugs; 2005; 19(8):717-8. PubMed ID: 16097853
    [No Abstract]   [Full Text] [Related]  

  • 38. A retrospective analysis of changing from alternative agents to carbamazepine extended-release capsules in bipolar disorder.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():31-4. PubMed ID: 16754411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I Disorder.
    Weisler RH; Kalali AH; Cutler AJ; Gazda TD; Ginsberg L
    Psychiatry (Edgmont); 2008 Mar; 5(3):35-48. PubMed ID: 22778707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical considerations for carbamazepine use in bipolar disorder.
    Fuller MA; Dostrow V; Gupta S; Gazda TD
    Expert Opin Drug Saf; 2006 Jul; 5(4):501-9. PubMed ID: 16774489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.